106 related articles for article (PubMed ID: 27397134)
1. Hydroxyapatite nanocrystals as a smart, pH sensitive, delivery system for kiteplatin.
Lelli M; Roveri N; Marzano C; Hoeschele JD; Curci A; Margiotta N; Gandin V; Natile G
Dalton Trans; 2016 Aug; 45(33):13187-95. PubMed ID: 27397134
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.
Thomas SC; Sharma H; Rawat P; Verma AK; Leekha A; Kumar V; Tyagi A; Gurjar BS; Iqbal Z; Talegaonkar S
Colloids Surf B Biointerfaces; 2016 Oct; 146():852-60. PubMed ID: 27455405
[TBL] [Abstract][Full Text] [Related]
3. Hollow mesoporous hydroxyapatite nanostructures; smart nanocarriers with high drug loading and controlled releasing features.
Munir MU; Ihsan A; Sarwar Y; Bajwa SZ; Bano K; Tehseen B; Zeb N; Hussain I; Ansari MT; Saeed M; Li J; Iqbal MZ; Wu A; Khan WS
Int J Pharm; 2018 Jun; 544(1):112-120. PubMed ID: 29678543
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-loaded hydroxyapatite/collagen hybrid gels as drug delivery systems for metastatic cancer cells.
Watanabe K; Nishio Y; Makiura R; Nakahira A; Kojima C
Int J Pharm; 2013 Mar; 446(1-2):81-6. PubMed ID: 23402979
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous hydroxyapatite nanoparticles hydrothermally synthesized in aqueous solution with hexametaphosphate and tea polyphenols.
Zhou H; Yang M; Hou S; Deng L
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():439-445. PubMed ID: 27987729
[TBL] [Abstract][Full Text] [Related]
6. PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study.
Arduino I; Depalo N; Re F; Dal Magro R; Panniello A; Margiotta N; Fanizza E; Lopalco A; Laquintana V; Cutrignelli A; Lopedota AA; Franco M; Denora N
Int J Pharm; 2020 Jun; 583():119351. PubMed ID: 32339634
[TBL] [Abstract][Full Text] [Related]
7. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y
Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364
[TBL] [Abstract][Full Text] [Related]
8. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
[TBL] [Abstract][Full Text] [Related]
9. Adsorption of the cis-[Pt(NH3)2(P2O7)](2-) (phosphaplatin) on hydroxyapatite nanocrystals as a smart way to selectively release activated cis-[Pt(NH3)2Cl2] (cisplatin) in tumor tissues.
Benedetti M; De Castro F; Romano A; Migoni D; Piccinni B; Verri T; Lelli M; Roveri N; Fanizzi FP
J Inorg Biochem; 2016 Apr; 157():73-9. PubMed ID: 26828286
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
Luo Y; Ling Y; Guo W; Pang J; Liu W; Fang Y; Wen X; Wei K; Gao X
J Control Release; 2010 Oct; 147(2):278-88. PubMed ID: 20655966
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
Abbasi Aval N; Pirayesh Islamian J; Hatamian M; Arabfirouzjaei M; Javadpour J; Rashidi MR
Int J Pharm; 2016 Jul; 509(1-2):159-167. PubMed ID: 27234695
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of hydroxyapatite nanocrystals with human immunoglobulin G for nanomedical applications.
Iafisco M; Varoni E; Di Foggia M; Pietronave S; Fini M; Roveri N; Rimondini L; Prat M
Colloids Surf B Biointerfaces; 2012 Feb; 90():1-7. PubMed ID: 22015181
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation of lipophilic kiteplatin Pt(iv) prodrugs in PLGA-PEG micelles.
Margiotta N; Savino S; Denora N; Marzano C; Laquintana V; Cutrignelli A; Hoeschele JD; Gandin V; Natile G
Dalton Trans; 2016 Aug; 45(33):13070-81. PubMed ID: 27094010
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of adenosine 5'-triphosphate using chitosan-coated mesoporous hydroxyapatite: A theranostic pH-sensitive nanoplatform with enhanced anti-cancer effect.
Feiz MS; Meshkini A
Int J Biol Macromol; 2019 May; 129():1090-1102. PubMed ID: 30170062
[TBL] [Abstract][Full Text] [Related]
15. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
16. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles.
Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW
Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062
[TBL] [Abstract][Full Text] [Related]
17. Silica xerogels and hydroxyapatite nanocrystals for the local delivery of platinum-bisphosphonate complexes in the treatment of bone tumors: a mini-review.
Iafisco M; Margiotta N
J Inorg Biochem; 2012 Dec; 117():237-47. PubMed ID: 22824154
[TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled Antitumor Drug Delivery.
Zeng J; Du P; Liu L; Li J; Tian K; Jia X; Zhao X; Liu P
Mol Pharm; 2015 Dec; 12(12):4188-99. PubMed ID: 26554495
[TBL] [Abstract][Full Text] [Related]
19. An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery.
Li S; Su Z; Sun M; Xiao Y; Cao F; Huang A; Li H; Ping Q; Zhang C
Int J Pharm; 2012 Oct; 436(1-2):248-57. PubMed ID: 22732672
[TBL] [Abstract][Full Text] [Related]
20. Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy.
Paraskar A; Soni S; Roy B; Papa AL; Sengupta S
Nanotechnology; 2012 Feb; 23(7):075103. PubMed ID: 22275055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]